SCHEMBL3348596

SCHEMBL3348596

CCCCCCCCCc1ccccc1S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.58
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
CYSLTR2 Q9NS75 6/20 0.46
CYSLTR1 Q9Y271 6/20 0.46
BID P55957 3/20 0.45
MCL1 Q07820 3/20 0.45
BCL2L1 Q07817 2/20 0.45
BAK1 Q16611 2/20 0.45
KAT8 Q9H7Z6 2/20 0.45
TLR8 Q9NR97 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
EP300 Q09472 1/20 0.45
KAT2A Q92830 1/20 0.45
KAT2B Q92831 1/20 0.45
KAT5 Q92993 1/20 0.45
SAE1 Q9UBE0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800366 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL30118162 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL28134408 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL11353366 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL2552510 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL786162 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL28981353 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL29478084 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL3348597 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL2557787 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220009-A1 ANTI-TARNISH COATING Enthone, Inc. (US) 2010-08-25 EP claimed
EP-2142485-A1 METALLIC SURFACE ENHANCEMENT Enthone, Inc. (US) 2010-01-13 EP claimed
WO-2009067446-A1 ANTI-TARNISH COATING ENTHONE INC. (US) 2009-05-28 WO claimed
WO-2008131206-A1 METALLIC SURFACE ENHANCEMENT ENTHONE INC. (US) 2008-10-30 WO claimed
CN-117321179-A Low ash lubricating oil composition 雪佛龙日本有限公司 2023-12-29 CN disclosed
CN-116391017-A Friction modifier system 雪佛龙日本有限公司 2023-07-04 CN disclosed
CN-111205424-B Modified resin and resin composition 旭化成株式会社 2022-04-08 CN disclosed
CN-113929866-A Modified resin and resin composition 旭化成株式会社 2022-01-14 CN disclosed
US-11192853-B2 Separation method and method for producing isocyanate ASAHI KASEI CHEMICALS CORPORATION (JP) 2021-12-07 US disclosed
CN-107629183-B Modified resin and resin composition 旭化成株式会社 2021-01-05 CN disclosed
EP-2641896-B1 SEPARATION METHOD ASAHI CHEMICAL IND (JP) 2020-10-14 EP disclosed
CN-111205424-A Modified resin and resin composition 旭化成株式会社 2020-05-29 CN disclosed
EP-0238629-A1 COMPOSITION COMPRISING A TRANSITION METAL OR LEAD COMPLEX OF A MANNICH BASE AND AN OXIM AND ITS USE AS A FUEL ADDITIVE. LUBRIZOL CORP (US) 1987-09-30 EP disclosed
EP-0238632-A1 METAL COMPLEXES OF MANNICH BASES. LUBRIZOL CORP (US) 1987-09-30 EP disclosed
US-4673412-A STORAGE STABILITY THE LUBRIZOL CORPORATION (US) 1987-06-16 US disclosed
CN-86106275-A The fuel dope and the fuel composition thereof that contain metallic compound and oxime 1987-05-13 CN disclosed
WO-1987001720-A1 FUEL ADDITIVE COMPRISING A METAL COMPOUND AND AN OXIME AND FUEL COMPOSITIONS CONTAINING SAME THE LUBRIZOL CORPORATION (US) 1987-03-26 WO disclosed
WO-1987001721-A1 METAL COMPLEXES OF MANNICH BASES THE LUBRIZOL CORPORATION (US) 1987-03-26 WO disclosed
US-4404408-A METAL OR NONMETAL COMPLEXES WITH GLYCIDOL, GLYCEROL ETHERS OR GLYCEROL THIOETHERS CIBA-GEIGY CORPORATION (US) 1983-09-13 US disclosed
US-4025316-A POLYMERIC ALKYL HYDROXY BENZYL AMINES, DETERGENTS, ANTIOXIDANTS, GASOLINE, LUBRICATING OIL EXXON RESEARCH AND ENGINEERING COMPANY (US) 1977-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192853-B2 Separation method and method for producing isocyanate IDH3A, IDH3B, CA9 LIPG 2340/4885THRA 4694/4885THRB 4460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.